| REVIEW ARTICLE |
|
| Year : 2022 | Volume
: 2
| Issue : 2 | Page : 67-74 |
|
|
Omics approaches in cancer management: Focussing on biobanks as emerging platforms for biomarker-based precision oncology
Abhishek Mohanty1, Daniel Catchpoole2
1 Centre for Biorepository and Biobanking, Health Care Global Enterprises Limited, Bengaluru, Karnataka, India
2 The Tumour Bank Kids Research Institute, The Children's Hospital, Westmead, Australia
Correspondence Address:
Dr. Abhishek Mohanty
HCG Centre for Biorepository and Biobanking, Health Care Global Enterprises Limited, HCG Towers, #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/jpo.jpo_18_22
|
|
|
Biobanks provide a platform for innovative biomedical research of cancer etiology, progression, and prognosis and have improvised translational and personalized medicine to a great extent. They form the cornerstone, providing resources for future investigations and helping us understand the effects of genetic, environmental, and lifestyle factors on human morbidity, mortality, and health. Time 2009 published ten ideas changing the world right now with biobanks providing linkage to clinical, pathologic, and epidemiologic data of emphasizing its role in discovering and developing biomarkers in new therapeutic drugs. In this review, we highlight the emergence of biobanks as definitive platforms for biomarker discovery-based precision oncology as well as its potential to facilitate bench-to-bedside oriented and multiomics-based translational cancer research.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
